<DOC>
	<DOCNO>NCT00552266</DOCNO>
	<brief_summary>This study evaluate safety effectiveness methylphenidate treat attention deficit hyperactivity disorder ( ADHD ) child ADHD trichotillomania . Trichotillomania impulse control disorder . There grow evidence involvement dopaminergic neurotransmission pathophysiology trichotillomania . Reported increase prevalence ADHD among patient impulse control disorder , pathological gamble well trichotillomania , may result overlap pathophisiological background . It hypothesize case ADHD comorbid trichotillomania methtylphenidate treatment exhibit beneficial effect ADHD hair pull .</brief_summary>
	<brief_title>Methylphenidate ADHD With Trichotillomania</brief_title>
	<detailed_description>Thirty child adolescent age 6-18 year , diagnose ADHD trichotillomania , receive MPH monotherapy treatment period 12 week , target ADHD trichotillomania symptom rat ADHD- rating scale ( ADHD-RS ) Massachusetts General Hospital Hair Pulling Scale Clinical Global Impression-Severity ( CGI ) scale . The rating scale assess baseline endpoint ( 12 week ) .The side effect monitor via weekly spontaneous self report participant . All result express mean Â±SD . Student 's pair t-test ANOVA test use appropriate .</detailed_description>
	<mesh_term>Trichotillomania</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>DSMIV Diagnosis trichotillomania DSMIV diagnosis ADHD Has take stimulant alphaadrenergic medication 2 week prior enter study . History moderate severe adverse event , related MPH History psychotic disorder Current drug abuse , acute psychotic affective disorder</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Methylphenidate</keyword>
	<keyword>Trichotillomania</keyword>
	<keyword>Attention deficit</keyword>
</DOC>